First case report of acute myeloid sarcoma post renal transplant.

Transplant Proc

Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.

Published: September 2014

Background: Although lymphoproliferative disorders are well-described and known entities post renal transplantation, acute myeloid sarcoma is a rare if ever reported occurrence in this setting. Immunosuppressive therapy is thought to be the main culprit in these cases.

Case Report: A 51-year-old man underwent renal transplantation 3.5 years earlier from a living unrelated donor. His posttransplant history was relevant for a road traffic accident after which a rise in the serum creatinine warranted 4 renal biopsies over a period of 7 months. The biopsies showed mainly acute tubular injury with sharp increase of the interstitial fibrosis and tubular atrophy between the first and the last biopsies. The patient was put on hemodialysis for 7 months, after which the allograft started functioning. The patient was followed a routinely, until he re-presented with increased creatinine and was found to have intra- and perirenal masses. Biopsies revealed acute myeloid sarcoma. The patient was started on fludarabine and cytosine arabinoside followed by All-trans retinoic acid and arsenic trioxide.

Conclusions: The patient was disease free on his last positron emission tomography 1 year after the initial diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2014.02.007DOI Listing

Publication Analysis

Top Keywords

acute myeloid
12
myeloid sarcoma
12
post renal
8
renal transplantation
8
case report
4
acute
4
report acute
4
sarcoma post
4
renal
4
renal transplant
4

Similar Publications

An adolescent girl with acute myeloid leukaemia underwent chemotherapy followed by haematopoietic stem cell transplantation (HSCT). Post-HSCT, she developed oral chronic graft-versus-host disease (cGvHD), which was successfully treated. Twenty months later, she was referred to the gynaecology department for evaluation of secondary amenorrhoea.

View Article and Find Full Text PDF

Bioorthogonal chemical reporters for profiling retinoic acid-modified and retinoic acid-interacting proteins.

Bioorg Med Chem

January 2025

State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China. Electronic address:

Vitamin A and its primary active derivative, all-trans retinoic acid (RA), are endogenous signaling molecules essential for numerous biological processes, including cell proliferation, differentiation, and immune modulation. Owing to its differentiation-inducing effect, RA was the first differentiating agent approved for the clinical treatment of acute myeloid leukemia. While the classical mechanisms of RA signaling involve nuclear receptors, such as retinoic acid receptors (RARs), emerging evidence suggests that RA also engages in non-covalent and covalent interactions with a broader range of proteins.

View Article and Find Full Text PDF

Background And Aims: Alcohol-related liver disease (ALD) is one of the leading causes of severe liver disease with limited pharmacological treatments for alcohol-related steatohepatitis (ASH). CD44, a glycoprotein mainly expressed in immune cells, has been implicated in multiple inflammatory diseases but has never been studied in the ALD context. We therefore studied its contribution to ASH development in mice and its expression in ALD patients.

View Article and Find Full Text PDF

Background: AML-M4Eo is a type of AML characterized by malignant proliferation of granulocyte and monocyte precursor cells accompanied by eosinophilia. Patients present as anemia, infection, bleeding, and tissue and organ infiltration. MICM classification makes the classification of AML more accurate and lays a foundation for the correct treatment and prognosis of AML.

View Article and Find Full Text PDF

Background: Acute myeloid leukemia (AML) is a hematologic malignancy. It is the most common form of acute leukemia among adults. Recent treatment advances have drastically improved outcomes for these diseases, but the overall survival (OS) is still exceptionally low due to the infiltration of leukemic cells in the central nervous system (CNS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!